The clinical guiding value of a radiomics model for androgen deprivation therapy for prostate cancer
Objective Three models were used to evaluate prostate cancer after androgen deprivation therapy (ADT) and to determine the value of detecting residual lesions after treatment. Methods We retrospectively analysed patients with prostate cancer who received ADT from January 2018 to June 2019. Patients...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-06-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605211014301 |